[Recent progress in leukemic stem cell research for childhood leukemia].
Mariko Eguchi1, Minenori Eguchi-Ishimae, Eiichi Ishii
1Department of Pediatrics, Ehime University Graduate School of Medicine.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 14, 2015
Summary
Leukemic stem cells (LSCs) initiating leukemia differ between acute myeloid leukemia (AML) and childhood acute lymphoblastic leukemia (ALL). Understanding LSC biology is key for developing targeted anti-cancer therapies.
Area of Science:
- Hematology
- Oncology
- Stem Cell Biology
Context:
- Leukemic stem cells (LSCs) are crucial for leukemia initiation and propagation.
- LSCs were first identified in acute myeloid leukemia (AML) using xenograft models.
- Research aims to clarify LSC identity and therapeutic targets across various cancers.
Purpose:
- To differentiate the characteristics and behavior of LSCs in AML versus childhood acute lymphoblastic leukemia (ALL).
- To explore the distinct models of leukemia propagation in AML and ALL.
- To identify potential genetic and cellular targets for novel anti-cancer therapies.
Summary:
- In AML, LSCs reside in the CD34+CD38- population and drive leukemia hierarchically.
- In childhood ALL, LSCs are found within CD19+ B-lineage progenitors, propagating leukemia via a stochastic model.
- LSCs in ALL arise from genetic alterations in self-renewing progenitors, gaining growth advantages.
Impact:
- Clarifying LSC heterogeneity is essential for understanding leukemia pathogenesis.
- Identifying specific LSC populations and their unique features can lead to more effective, targeted therapies.
- This research contributes to the development of improved anti-cancer treatments by highlighting LSC-specific vulnerabilities.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Stem Cell Therapy for Tissue Regeneration
4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Lineage Commitment
4.6K
Commitment is the process whereby stem cells:
4.6K
Regulation of Hematopoietic Stem Cells
4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Differentiation of Common Myeloid Progenitor Cells
4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K


